IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory · Investor's Business Daily
ALLISON GATLIN
2 min read

In This Article:

Hims stock jumped early Tuesday after the online pharmacy beat expectations, helped by Hims & Hers' weight-loss drug.

Recommended Stories